BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7600743)

  • 1. Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients? QTc interval measure versus standardized tests in diabetic autonomic neuropathy.
    Veglio M; Chinaglia A; Borra M; Perin PC
    Diabet Med; 1995 Apr; 12(4):302-6. PubMed ID: 7600743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes.
    Sivieri R; Veglio M; Chinaglia A; Scaglione P; Cavallo-Perin P
    Diabet Med; 1993 Dec; 10(10):920-4. PubMed ID: 8306587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.
    Pappachan JM; Sebastian J; Bino BC; Jayaprakash K; Vijayakumar K; Sujathan P; Adinegara LA
    Postgrad Med J; 2008 Apr; 84(990):205-10. PubMed ID: 18424578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QTc-interval, heart rate variability and postural hypotension as an indicator of cardiac autonomic neuropathy in type 2 diabetic patients.
    Khoharo HK; Halepoto AW
    J Pak Med Assoc; 2012 Apr; 62(4):328-31. PubMed ID: 22755273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy.
    Langen KJ; Ziegler D; Weise F; Piolot R; Boy C; Hübinger A; Gries FA; Müller-Gärtner HW
    Clin Sci (Lond); 1997 Oct; 93(4):325-33. PubMed ID: 9404224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of corrected QT interval in autonomic function testing: assessment of reproducibility.
    Veglio M; Maule S; Matteoda C; Quadri R; Valentini M; Pecchio O; Piancino G; Chiandussi L
    Clin Auton Res; 1996 Dec; 6(6):309-12. PubMed ID: 8985618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of corrected QT intervals in diabetic autonomic neuropathy in patients with type 2 diabetes.
    Takebayashi K; Aso Y; Sugita R; Takemura Y; Inukai T
    Diabetes Metab; 2002 Apr; 28(2):127-32. PubMed ID: 11976564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [QT dispersion in insulin-dependent diabetics].
    Galetta F; Franzoni F; Prattichizzo F; Tintori G; Cinotti F; Taccola D; Giusti C
    G Ital Cardiol; 1999 Jun; 29(6):675-8. PubMed ID: 10396672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnostic value of the rate-corrected QT interval in long-term type-1 diabetes mellitus].
    Schnell O; Stenner T; Standl E; Haslbeck M
    Dtsch Med Wochenschr; 1996 Jun; 121(25-26):819-22. PubMed ID: 8665827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QTc interval, and autonomic and somatic nerve function in diabetic neuropathy.
    Katsuoka H; Mimori Y; Kurokawa K; Harada T; Kohriyama T; Ishizaki F; Harada A; Nakamura S
    Clin Auton Res; 1998 Jun; 8(3):139-43. PubMed ID: 9651663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT prolongation on the electrocardiogram in diabetic autonomic neuropathy.
    Chambers JB; Sampson MJ; Sprigings DC; Jackson G
    Diabet Med; 1990 Feb; 7(2):105-10. PubMed ID: 2137748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corrected QT interval and diabetic neuropathy of the cardiovascular system].
    Klupa T; Mroczek T; Galicka-Latała D; Kozek E; Sieradzki J
    Przegl Lek; 1995; 52(12):583-7. PubMed ID: 8834655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy.
    Kahn JK; Sisson JC; Vinik AI
    J Clin Endocrinol Metab; 1987 Apr; 64(4):751-4. PubMed ID: 3818902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurable deficit of autonomic and sensory nerve function in asymptomatic diabetic patients.
    Piaggesi A; Castro Lòpez E; Bini L; Benzi L; Giampietro O; Schipani E; Navalesi R
    J Diabetes Complications; 1992; 6(3):157-62. PubMed ID: 1472740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis.
    Whitsel EA; Boyko EJ; Siscovick DS
    Diabetes Care; 2000 Feb; 23(2):241-7. PubMed ID: 10868838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Utility of QTc interval for the diagnosis of cardiac autonomic neuropathy in type 2 diabetes mellitus].
    Matel D; Chiochină AD; Stratone A
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):282-6. PubMed ID: 20509317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of recently diagnosed autonomic neuropathy over a period of 2 years.
    Karamitsos DT; Didangelos TP; Athyros VG; Kontopoulos AG
    Diabetes Res Clin Pract; 1998 Oct; 42(1):55-63. PubMed ID: 9884034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT interval length and diabetic autonomic neuropathy.
    Ewing DJ; Neilson JM
    Diabet Med; 1990 Jan; 7(1):23-6. PubMed ID: 2137059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrected QT interval in relation to the severity of diabetic autonomic neuropathy.
    Tentolouris N; Katsilambros N; Papazachos G; Papadogiannis D; Linos A; Stamboulis E; Papageorgiou K
    Eur J Clin Invest; 1997 Dec; 27(12):1049-54. PubMed ID: 9466135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic autonomic neuropathy.
    Vinik AI; Maser RE; Mitchell BD; Freeman R
    Diabetes Care; 2003 May; 26(5):1553-79. PubMed ID: 12716821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.